60 items

New gene therapy delivery system aims for precision

May 4, 2020

In a novel approach to gene therapy, scientists funded by the National Eye Institute (NEI) report using gold nanoparticles and light to target specific cells in mouse retina.

Florida Atlantic Scientists land NEI grant for tissue engineering approach

April 3, 2020

The Kantorow Laboratory and research program have been continually funded by the NIH’s National Eye Institute for almost two decades.

Therapy could improve, prolong sight in those suffering vision loss

March 13, 2020

Millions of Americans are progressively losing their sight as cells in their eyes deteriorate, but a new therapy developed by researchers at the University of California, Berkeley, could help prolong useful vision and delay total blindness.

Scientists successfully test new way to deliver gene therapy​

March 6, 2020

Researchers at Case Western Reserve University have used a unique method to safely deliver gene therapy to fight a rare, but irreversible, genetic eye disorder known as Stargardt disease.

Tech that detects cause of preemie blindness gets federal nod

January 30, 2020

An artificial intelligence algorithm that can detect a potentially devastating cause of childhood blindness better than most human experts has been granted breakthrough status by the FDA.

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace and repair dying cells in retina

December 16, 2019

Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration.

Joslin Researchers Uncover Protective Factor in Diabetic Eye Disease

July 3, 2019

Researchers at Joslin Diabetes Center have shown that a protein found in the eye can protect against and potentially treat diabetic eye disease.

New Treatment for Severe Dry Eye Disease Promising in Early Clinical Trials

May 7, 2019

Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a paper in Translational Vision Science and Technology.

Experimental Drug Delivers One-Two Punch to Vision Loss

April 10, 2019

In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimental drug may be twice as good at fighting vision loss as previously thought.

New Study Reshapes Understanding of How the Brain Recovers from Injury

March 20, 2019

New research, which appears in the journal Proceedings of the Royal Society B, sheds light on how the damage in the brain caused by a stroke can lead to permanent vision impairment for approximately 265,000 Americans each year.